The Alzheimer’s Association has published an analysis of a 2024 RAND report that outlines the health, community, and economic benefits of more systemic and deliberate investment in the treatment of Alzheimer’s disease in adults with Down syndrome.
PCORI funds study of new approach to Sleep Apnea treatment
Summer internship leads to new analysis of Down syndrome research
The medical advances made within the Down syndrome community over
10/1/2024 | For immediate release | Contact: Kate O’Neill ([email protected])
Project will empower advocates, enhance research for people at high
Information revealed at the 2024 AAIC conference on the ACTC-DS-led
Major pharmaceutical company announces Down syndrome population will see a
James Lind, a United Kingdom’s Royal Navy surgeon, is considered
“Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down
LuMind IDSC is encouraged by today’s news that the U.S.
Medicare, Medicaid and Dual Enrollment for Adults with IDD Boston
